Affordable Medicines Ireland Company CLG (Affordable Medicines Ireland)

Lobbying Organisation Affordable Medicines Ireland Company CLG

Date published 19 Jan, 2026

Relevant Matter Public policy or programme

Public Policy Area Health

Period 1 Sep, 2025 to 31 Dec, 2025

Specific Details Representations to officials and a Ministerial adviser from Affordable Medicines Ireland concerning the framework pricing agreement on medicines.

Intended results Representations to the Department of Health concerning the successor agreement on the framework pricing of medicines requesting that Affordable Medicines Ireland, which represents parallel imports of medicines, would be consulted on any successor agreement to reflect the important role that parallel imports of medicines plays in supporting patient access to medicines and helping address medicines shortages.

Name of person primarily responsible for lobbying on this activity Patrick Wadding, Chairperson, Affordable Medicines Ireland

Did any Designated Public Official(DPO) or former Designated Public Official(DPO) carry out lobbying activities on your behalf in relation to this return? You must include yourself, and answer Yes, if you are a current DPO or a DPO at any time in the past. (What is a Designated Public Official?) No

Did you manage or direct a grassroots campaign? No

Was this lobbying done on behalf of a client? No

Lobbying activity

The following activities occurred for this specific Subject Matter Area.

Email (2-5)

Email to Dept officials and Special Ministerial Advisor referring to previous correspondence requesting the participation of Affordable Medicines Ireland in any discussions surrounding a successor framework pricing agreement on medicines.

Designated public officials lobbied

The following DPOs were lobbied during this return period on this specific Subject Matter Area. These DPOs were involved in at least one of the Lobbying Activities listed above, but not necessarily all of them. As returns are specific to a Subject Matter Area the above Lobbying Activities may be associated with multiple returns.

Stephen Foley Special Adviser (Department of Health)